Cargando…
Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity
To study the effects of localized secretion of cytokines on tumor progression, the gene for human interleukin 2 (IL-2) was introduced via retroviral vectors into CMS-5 cells, a weakly immunogenic mouse fibrosarcoma cell line of BALB/c origin. Secretion of low levels of IL- 2 from the tumor cells abr...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1990
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2188618/ https://www.ncbi.nlm.nih.gov/pubmed/2212951 |
Ejemplares similares
-
Passive immunization against tumor necrosis factor partially abrogates interleukin 2 toxicity
Publicado: (1989) -
The β-carboline Harmine Induces Actin Dynamic Remodeling and Abrogates the Malignant Phenotype in Tumorigenic Cells
por: Le Moigne, Ronan, et al.
Publicado: (2020) -
Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogates metastasis by K-1735 murine melanoma cells
Publicado: (1995) -
Adenovirus-mediated interleukin 21 gene transfer enhances antitumor immunity and reduces tumorigenicity of Hepa1–6 in mice
por: Ju, Jiyu, et al.
Publicado: (2016) -
Vector Transmission of Leishmania Abrogates Vaccine-Induced Protective Immunity
por: Peters, Nathan C., et al.
Publicado: (2009)